GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment

Overview of attention for article published in Pharmacological Research, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 1 blog
twitter: 18 X users

reddit: 1 Redditor

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 19 X posts from 18 X users, with an upper bound of 48,603 followers.

RT @MichaelAlbertMD: In people at risk of bone demineralization, I generally prefer tirzepatide over semaglutide. Pre-clinical and clinical…

In people at risk of bone demineralization, I generally prefer tirzepatide over semaglutide. Pre-clinical and clinical data suggest that tirzepatide (via GIP activity) directly affects bone by decreasing bone resorption and enhancing bone anabolism. htt…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 15 additional X posts.